Clinical Trial Insights

Kim shares her motivation to get involved in clinical trials to improve outcomes for individuals with type 1 diabetes, highlighting her missed opportunity to participate in the Protect study. Scott mentions his recent conversation with Carla Greenbaum, a key figure in the Protect study, adding depth to Kim's experience.